Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
2023
>
26
>
6
Volume:
26
Issue:
6
1. Updated Interpretation of the NCCN Clinical Practice Guidelines (Version 3. 2023) for Non-small Cell Lung Cancer.
Page:407—415
2. Expert Consensus on Targeted Therapy of NSCLC with MET Exon 14 Skipping Mutation.
Page:416—428
3. Effect of Different Antitumor Regimens on Incidence and Severity of Corona Virus Disease 2019 Pneumonia in Lung Cancer Patients: A Single-center Retrospective Study.
Page:429—438
4. Incidence and Risk Factors of Venous Thromboembolism in Patients with Lung Adenocarcinoma Receiving Anti-tumor Therapy.
Page:439—448
5. CTCs Detection and Whole-exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules.
Page:449—460
6. Role of Adverse Events Supervision in Clinical Trials in Neoadjuvant Treatment of Operable Stage III NSCLC.
Page:461—466
7. Research Progress on the Protective Effect of Intestinal Flora on Radiation-induced Lung Injury in Thoracic Tumors.
Page:467—472
8. Research Progress of Klotho in Lung Neoplasms.
Page:473—478
9. Retraction of "Altered Treg and IL-1A Expression in the Immune Microenvironment of Lung Squamous-cell Cancer after EGFR Blockade. Zhongguo Feiai Zazhi, 2017, 20(3): 143-148.".
Page:448—448